A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis

Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis

(2011) M. M. Gounder et al.   CLINICAL CANCER RESEARCH

Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer

(2011) Joyce N. Barlin et al.   GYNECOLOGIC ONCOLOGY

Predicting Survival After Curative Colectomy for Cancer: Individualizing Colon Cancer Staging

(2011) Martin R. Weiser et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation

(2011) Sébastien Salas et al.   JOURNAL OF CLINICAL ONCOLOGY

Familial Adenomatous Polyposis-Associated Desmoids Display Significantly More Genetic Changes than Sporadic Desmoids

(2011) Els Robanus-Maandag et al.   PLoS One

Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells

(2010) C. Wu et al.   CANCER RESEARCH

Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment

(2009) Marco Fiore et al.   ANNALS OF SURGICAL ONCOLOGY

Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

(2008) Alexander J.F. Lazar et al.   AMERICAN JOURNAL OF PATHOLOGY

A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients

(2008) R. J. Canter et al.   CLINICAL CANCER RESEARCH

Long-Term Outcomes for Desmoid Tumors Treated With Radiation Therapy

(2008) B. Ashleigh Guadagnolo et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS